A. gambiae is the most common vector of human malaria in sub-Saharan Africa, where rates of the disease are highest. The researchers compared the genomes of two emerging species, dubbed M and S. Given that M and S appear to be physically indistinguishable and interbreed often, they were unexpectedly different at the DNA level.
They also were found to behave differently and thrive in different habitats. For example, in the absence of predators, S mosquitoes outcompeted M mosquitoes, but the outcome was reversed when predators were present.
As these two emerging species of mosquito evolve to develop new traits and behaviors, changes in disease transmission could result, the authors say. This could complicate malaria control efforts, which currently are based on the mosquitoes' patterns of behavior and vulnerability to insecticides.
Future research will further investigate these emerging species, exploring how they compete with one another in various habitats and the molecular basis of their evolution. The results will be used to refine existing malaria interventions and inform the development of new disease prevention strategies.
The research was supported by the National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute, both components of NIH. More information about NIAID research on malaria and other vector-borne diseases is available at the NIAID Malaria (http://www.niaid.nih.gov/topics/malaria/Pages/default.aspx) and the NIAID Vector Biology Web portals (http://www.niaid.nih.gov/topics/vector/pages/default.aspx).
ARTICLES: DE Neafsey et al. Complex gene-flow boundaries among vector mosquito populations. Science. DOI: 10.1126/science.1193036 (2010).
MKN Lawniczak et al. Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science. DOI: 10.1126/science.1195755 (2010).
WHO: Adriana Costero-Saint Denis, Ph.D., of the Parasitology and International Programs Branch, NIAID, is available to comment on these articles.
CONTACT: To schedule interviews, please contact Nalini Padmanabhan, 301-402-1663, email@example.com.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases.
Spanish scientists create a 3-D bioprinter to print human skin
24.01.2017 | Carlos III University of Madrid
Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital
A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...
For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.
According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
24.01.2017 | Physics and Astronomy
24.01.2017 | Life Sciences
24.01.2017 | Health and Medicine